Eminat, LLC - Miramar — Miramar, Florida

Eminat, LLC - Miramar is a clinical research site located in Miramar, Florida, United States 33027.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Eminat, LLC - Miramar has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Inflammatory Bowel Diseases, Colitis, Ulcerative.

Sponsors: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Miramar

Browse all research sites in Florida · View every site in Miramar

• South Broward Research
• FXM Research Miramar
• Comprehensive Phase One
• FXM Clinical Research Miramar
• GSK Investigational Site
• Innovia Research Center
• FXM Clin Res Miramar LLC
• Sage Investigational Site
• Research Site
• Novartis Investigative Site
• Galderma Investigational Site
• FXM Research

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Eminat, LLC - Miramar?

Eminat, LLC - Miramar has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Eminat, LLC - Miramar conducted?

Eminat, LLC - Miramar has 1 clinical trials on record, with 1 currently active. Their work covers Inflammatory Bowel Diseases, Colitis, Ulcerative.

Is Eminat, LLC - Miramar accredited by Crixeo Clinical Trials?

Eminat, LLC - Miramar has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Eminat, LLC - Miramar?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.